Logo image of VHI

VALHI INC (VHI) Stock Fundamental Analysis

NYSE:VHI - New York Stock Exchange, Inc. - US9189052098 - Common Stock - Currency: USD

17.34  -0.21 (-1.2%)

After market: 17.34 0 (0%)

Fundamental Rating

5

Overall VHI gets a fundamental rating of 5 out of 10. We evaluated VHI against 85 industry peers in the Chemicals industry. VHI has only an average score on both its financial health and profitability. VHI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

VHI had positive earnings in the past year.
VHI had a positive operating cash flow in the past year.
Of the past 5 years VHI 4 years were profitable.
Each year in the past 5 years VHI had a positive operating cash flow.
VHI Yearly Net Income VS EBIT VS OCF VS FCFVHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

VHI's Return On Assets of 3.86% is fine compared to the rest of the industry. VHI outperforms 71.76% of its industry peers.
VHI has a better Return On Equity (10.42%) than 74.12% of its industry peers.
The Return On Invested Capital of VHI (5.22%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.86%
ROE 10.42%
ROIC 5.22%
ROA(3y)2.2%
ROA(5y)2.55%
ROE(3y)6.18%
ROE(5y)8.39%
ROIC(3y)N/A
ROIC(5y)N/A
VHI Yearly ROA, ROE, ROICVHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

Looking at the Profit Margin, with a value of 5.13%, VHI is in the better half of the industry, outperforming 67.06% of the companies in the same industry.
In the last couple of years the Profit Margin of VHI has grown nicely.
Looking at the Operating Margin, with a value of 8.09%, VHI is in line with its industry, outperforming 47.06% of the companies in the same industry.
In the last couple of years the Operating Margin of VHI has grown nicely.
VHI's Gross Margin of 20.26% is on the low side compared to the rest of the industry. VHI is outperformed by 64.71% of its industry peers.
VHI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.09%
PM (TTM) 5.13%
GM 20.26%
OM growth 3Y-11.53%
OM growth 5Y1.8%
PM growth 3Y-2.52%
PM growth 5Y14.63%
GM growth 3Y-7.09%
GM growth 5Y-2.42%
VHI Yearly Profit, Operating, Gross MarginsVHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for VHI remains at a similar level compared to 1 year ago.
The number of shares outstanding for VHI remains at a similar level compared to 5 years ago.
The debt/assets ratio for VHI is higher compared to a year ago.
VHI Yearly Shares OutstandingVHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
VHI Yearly Total Debt VS Total AssetsVHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that VHI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.76, VHI is in line with its industry, outperforming 44.71% of the companies in the same industry.
The Debt to FCF ratio of VHI is 42.68, which is on the high side as it means it would take VHI, 42.68 years of fcf income to pay off all of its debts.
VHI has a Debt to FCF ratio of 42.68. This is in the lower half of the industry: VHI underperforms 61.18% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that VHI is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.47, VHI is doing good in the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 42.68
Altman-Z 1.76
ROIC/WACC0.61
WACC8.51%
VHI Yearly LT Debt VS Equity VS FCFVHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

VHI has a Current Ratio of 2.26. This indicates that VHI is financially healthy and has no problem in meeting its short term obligations.
VHI has a Current ratio of 2.26. This is in the better half of the industry: VHI outperforms 63.53% of its industry peers.
VHI has a Quick Ratio of 1.19. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
VHI has a Quick ratio (1.19) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 1.19
VHI Yearly Current Assets VS Current LiabilitesVHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

VHI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 888.46%, which is quite impressive.
VHI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.04% yearly.
VHI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.53%.
The Revenue has been growing slightly by 2.10% on average over the past years.
EPS 1Y (TTM)888.46%
EPS 3Y-5.31%
EPS 5Y14.04%
EPS Q2Q%318.52%
Revenue 1Y (TTM)9.53%
Revenue growth 3Y-2.86%
Revenue growth 5Y2.1%
Sales Q2Q%1.51%

3.2 Future

The Earnings Per Share is expected to grow by 6.52% on average over the next years.
VHI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.77% yearly.
EPS Next Y0.91%
EPS Next 2Y6.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.92%
Revenue Next 2Y9.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VHI Yearly Revenue VS EstimatesVHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
VHI Yearly EPS VS EstimatesVHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.23, the valuation of VHI can be described as very cheap.
Based on the Price/Earnings ratio, VHI is valued cheaply inside the industry as 97.65% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 24.83, VHI is valued rather cheaply.
With a Price/Forward Earnings ratio of 4.72, the valuation of VHI can be described as very cheap.
Based on the Price/Forward Earnings ratio, VHI is valued cheaply inside the industry as 97.65% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.94, VHI is valued rather cheaply.
Industry RankSector Rank
PE 4.23
Fwd PE 4.72
VHI Price Earnings VS Forward Price EarningsVHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

96.47% of the companies in the same industry are more expensive than VHI, based on the Enterprise Value to EBITDA ratio.
VHI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 37.16
EV/EBITDA 2.99
VHI Per share dataVHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.67
PEG (5Y)0.3
EPS Next 2Y6.52%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

VHI has a Yearly Dividend Yield of 1.82%. Purely for dividend investing, there may be better candidates out there.
VHI's Dividend Yield is comparable with the industry average which is at 3.80.
Compared to the average S&P500 Dividend Yield of 2.41, VHI is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.82%

5.2 History

The dividend of VHI decreases each year by -19.61%.
VHI has been paying a dividend for at least 10 years, so it has a reliable track record.
VHI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-19.61%
Div Incr Years0
Div Non Decr Years3
VHI Yearly Dividends per shareVHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

VHI pays out 8.43% of its income as dividend. This is a sustainable payout ratio.
DP8.43%
EPS Next 2Y6.52%
EPS Next 3YN/A
VHI Yearly Income VS Free CF VS DividendVHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
VHI Dividend Payout.VHI Dividend Payout, showing the Payout Ratio.VHI Dividend Payout.PayoutRetained Earnings

VALHI INC

NYSE:VHI (5/12/2025, 7:00:00 PM)

After market: 17.34 0 (0%)

17.34

-0.21 (-1.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06
Inst Owners4.64%
Inst Owner Change5.59%
Ins Owners0.14%
Ins Owner Change0%
Market Cap490.55M
Analysts42.5
Price Target20.4 (17.65%)
Short Float %2.13%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield 1.82%
Yearly Dividend0.32
Dividend Growth(5Y)-19.61%
DP8.43%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-17 2025-03-17 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.92%
Min EPS beat(2)32.23%
Max EPS beat(2)99.61%
EPS beat(4)3
Avg EPS beat(4)-741.85%
Min EPS beat(4)-3241.58%
Max EPS beat(4)142.33%
EPS beat(8)4
Avg EPS beat(8)-585.39%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 4.23
Fwd PE 4.72
P/S 0.23
P/FCF 37.16
P/OCF 11.12
P/B 0.47
P/tB 0.75
EV/EBITDA 2.99
EPS(TTM)4.1
EY23.64%
EPS(NY)3.68
Fwd EY21.2%
FCF(TTM)0.47
FCFY2.69%
OCF(TTM)1.56
OCFY8.99%
SpS74.4
BVpS36.62
TBVpS23.11
PEG (NY)4.67
PEG (5Y)0.3
Profitability
Industry RankSector Rank
ROA 3.86%
ROE 10.42%
ROCE 7.9%
ROIC 5.22%
ROICexc 6.23%
ROICexgc 7.9%
OM 8.09%
PM (TTM) 5.13%
GM 20.26%
FCFM 0.63%
ROA(3y)2.2%
ROA(5y)2.55%
ROE(3y)6.18%
ROE(5y)8.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-13.32%
ROICexcg growth 5Y5.94%
ROICexc growth 3Y-13.52%
ROICexc growth 5Y5.5%
OM growth 3Y-11.53%
OM growth 5Y1.8%
PM growth 3Y-2.52%
PM growth 5Y14.63%
GM growth 3Y-7.09%
GM growth 5Y-2.42%
F-Score6
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 42.68
Debt/EBITDA 2.04
Cap/Depr 46.33%
Cap/Sales 1.47%
Interest Coverage 3.78
Cash Conversion 18.61%
Profit Quality 12.22%
Current Ratio 2.26
Quick Ratio 1.19
Altman-Z 1.76
F-Score6
WACC8.51%
ROIC/WACC0.61
Cap/Depr(3y)83.84%
Cap/Depr(5y)91.05%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)888.46%
EPS 3Y-5.31%
EPS 5Y14.04%
EPS Q2Q%318.52%
EPS Next Y0.91%
EPS Next 2Y6.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.53%
Revenue growth 3Y-2.86%
Revenue growth 5Y2.1%
Sales Q2Q%1.51%
Revenue Next Year11.92%
Revenue Next 2Y9.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y628.88%
EBIT growth 3Y-14.06%
EBIT growth 5Y3.94%
EBIT Next Year57.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y128.95%
FCF growth 3Y-67.81%
FCF growth 5Y-35.4%
OCF growth 1Y1420.69%
OCF growth 3Y-54.22%
OCF growth 5Y-24.28%